Showing 3991-4000 of 21451 results for "".
- Minimally Invasive Options for Gastric Subepithelial Tumors Continue to Expand, Review Findshttps://reachmd.com/news/minimally-invasive-options-for-gastric-subepithelial-tumors-continue-to-expand-review-finds/2485641/Advances in therapeutic endoscopy are steadily reshaping how gastric subepithelial tumors (G-SETs) are managed, with a growing array of endoscopic and hybrid techniques offering alternatives to traditional surgery for selected patients.
- Systematic Review Finds Ceftolozane/Tazobactam Comparable to Standard Therapies for Resistant Gram-Negative Infectionshttps://reachmd.com/news/systematic-review-finds-ceftolozanetazobactam-comparable-to-standard-therapies-for-resistant-gram-negative-infections/2485633/A newly published systematic review synthesizing data from randomized controlled trials reports that ceftolozane/tazobactam demonstrates efficacy comparable to established comparator antibiotics across several s
- Revolutionizing Asthma Management: Insights into Novel Mechanistic Discoverieshttps://reachmd.com/news/revolutionizing-asthma-management-insights-into-novel-mechanistic-discoveries/2485498/Researchers propose a pseudo‑leukotriene–driven epithelial signaling axis as a distinct mechanism linking metabolic lipid media
- Delgocitinib Improves Patient-Reported Outcomes Across Chronic Hand Eczema Subtypeshttps://reachmd.com/news/delgocitinib-improves-patient-reported-outcomes-across-chronic-hand-eczema-subtypes/2485611/Patient-reported outcome (PRO) data from the phase 3 DELTA 1 and DELTA 2 trials suggest that topical delgocitinib cream provides clinically meaningful symptom relief across major subtypes of chronic hand eczema (CHE), according to a poster from Robert Bissonnette,
- PCCT for Lung Cancer: Clinical Performance and Procurement Implicationshttps://reachmd.com/news/pcct-for-lung-cancer-clinical-performance-and-procurement-implications/2485597/In a prospective study evaluating contrast-enhanced lung cancer CT and detection of enhancement-associated malignant features, photon-counting CT
- Advancements in Robotic-Assisted Intraocular Surgeries: A New Era of Precisionhttps://reachmd.com/news/advancements-in-robotic-assisted-intraocular-surgeries-a-new-era-of-precision/2485497/Retinal vein occlusion (RVO) remains one of the leading causes of vision loss worldwide, with limited therapeutic options that directly address the underlying blockage. But
- Octane Aesthetics Tech Forum: Panelists Discuss Innovation in Hair Loss Delivery, Regulationhttps://reachmd.com/news/octane-aesthetics-tech-forum-panelists-discuss-innovation-in-hair-loss-delivery-regulation/2485561/The future of hair restoration may be rooted in regenerative science, but panelists at the Octane Aesthetics Tech Forum agree: the real-world success of these advances hinges on how treatments are delivered and how they’re regulated. Speaking during the “Hiding in the Shadows of H
- Imagining a Better Future for Hidradenitis Suppurativahttps://reachmd.com/news/imagining-a-better-future-for-hidradenitis-suppurativa/2485556/Hidradenitis suppurativa (HS) has long been misunderstood, underdiagnosed, and undertreated. However, at a recent panel discussion led by Vivian Shi, MD, at
- Gene-Editing Innovations in Kidney Disease Treatment: A New Erahttps://reachmd.com/news/gene-editing-innovations-in-kidney-disease-treatment-a-new-era/2485536/Researchers reported preclinical evidence that CRISPR base editing can directly correct
- Innovative Nanocarrier Strategies to Overcome Drug Resistance in Esophageal Cancerhttps://reachmd.com/news/innovative-nanocarrier-strategies-to-overcome-drug-resistance-in-esophageal-cancer/2485525/Spatial targeting of the NTRK2–MAPK signaling axis represents a proposed translational strategy to address EGFR-TKI resistance in esophageal squamous cell carcinoma by directing nanocarriers to resistant, signaling-defined tumor niches. Rather than relying on diffuse